Navigation Links
Biotech Posts Weak Performance in April
Date:5/3/2010

chemicals.
  • Alimera Sciences priced at $11 a share, 29 percent below its target range of $15 to $17, raising $72 million. The Alpharetta, Georgia-based biotech's late-stage lead compound is a treatment for diabetic macular edema.

  • (For full details of the performance of the biotech IPOs see: www.burrillreport.com/article-2295.html)

    BY THE NUMBERS

    (Compiled by the Burrill Report*)

    • The industry closed the month with a collective market cap of $382 billion (no change for the month)
    • 56 biotech companies (18.6 percent) have market caps greater than $1B (compared to 49 companies at the same time last year)
    • The Burrill Biotech Select Index is up 5.6 percent year-to-date

    (*The April edition of the Burrill Report has a breakdown of the industry's Q1 2010 performance and copies are available on request.)

    About Burrill & Company

    Founded in 1994, Burrill & Company is a San Francisco-based global leader in life sciences with activities in Venture Capital, Private Equity, Merchant Banking and Media. The Burrill family of venture capital funds has over $950 million under management and its merchant banking business is one of the industry leaders in life sciences transactions
    '/>"/>

    SOURCE Burrill & Company
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
    2. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
    3. Ortho Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and Efficacy When Used According to Label
    4. CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
    5. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
    6. ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer
    7. Epeius Biotechnologies Applauds the Belated Scholarship of Their Academic Contemporaries in 2007, As Targeted Gene Therapy Comes of Age in Clinical Medicine
    8. Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
    9. Hawaii Biotech Receives Allowance to Perform West Nile Vaccine Clinical Trials
    10. Kibow Biotech Obtains Australian, Chinese and Indian Patents Protecting the Composition and Basic Technology Behind Its Oral Probiotic Formulation for Chronic Kidney Failure
    11. Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/29/2015)... July 29, 2015 Sangamo BioSciences, Inc. (NASDAQ: ... release its second quarter 2015 financial results after the ... release will be followed by a conference call at ... public via telephone and webcast. During the conference call, ... discuss other business matters. The conference call ...
    (Date:7/29/2015)... 29, 2015 Immune Pharmaceuticals Inc. (NASDAQ: IMNP ... up to $21.5 million through two financing agreements. The ... ) ("Hercules"), for a term loan of up to ... Growth Fund ("Discover"), for the sale to Discover of ... Stock") for up to $12 million in gross proceeds ...
    (Date:7/29/2015)... Washington , 29 luglio 2015 ... ha scoperto che l,ingestione quotidiana del probiotico ... intestinale umano e modifica la produzione intestinale di ... studio riguardava la somministrazione quotidiana di ceppo di ... SD-5865) in compresse utilizzando il sistema di somministrazione ...
    Breaking Medicine Technology:Sangamo BioSciences Announces Second Quarter 2015 Conference Call and Webcast 2Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 2Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 3Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 4Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 5Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 6Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 7È stato clinicamente dimostrato che il probiotico L. reuteri di Nutraceutix regola il metabolismo insulinico intestinale 2
    ... Dystrophy Association announced today that SMT C1100, an experimental ... received approval from regulatory agencies in the United Kingdom ... healthy human volunteers. (Logo: http://photos.prnewswire.com/prnh/20120424/DC93207LOGO ) ... of a muscle protein utrophin that can potentially compensate ...
    ... Argos Therapeutics Inc. today announced that it has ... the commencement of its Phase 3 ADAPT study in ... in mid-2012. The financing was led by Forbion Capital ... Capital, Intersouth Partners, Caisse de depot et placement du ...
    Cached Medicine Technology:SMT C1100 For Duchenne Muscular Dystrophy Moves To Human Testing 2SMT C1100 For Duchenne Muscular Dystrophy Moves To Human Testing 3Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012 2Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012 3
    (Date:7/30/2015)... ... , ... At the presentation of the 2015 Annual Meeting of the American Academy of ... the Journal of Arthroplasty pertaining to how soon after undergoing hip replacement surgery (THR) ... study confirm what Santa Rosa Orthopaedics (SRO) surgeon Nathan Ehmer D.O . ...
    (Date:7/30/2015)... ... July 30, 2015 , ... Case Mason ( http://www.casemason.com ), ... brands, recently completed a consolidation of all of its production capabilities to a ... of two separate locations situated 11 miles apart. , The advantages of consolidating ...
    (Date:7/30/2015)... ... , ... PeopleKeys, a company with over 30 years of experience in behavioral ... webinar, the newest installment in their popular DISC for the Real World series, will ... Trainer webinar is intended for people interested in training others to use DISC behavioral ...
    (Date:7/30/2015)... ... ... Addictions Training Institute has announced the launch of a fully ... Abuse Counselors. , "We are thrilled to be launching Addictions Training Institute,” said Ron ... and Drug Counselors nationwide. We are excited to be helping fill this need ...
    (Date:7/29/2015)... Francisco, California (PRWEB) , ... July 30, 2015 , ... ... Jimi Hendrix Dorton Arena Raleigh North Carolina concert posters. The same poster art was ... were printed by Globe Poster based in Baltimore and are classic boxing style concert ...
    Breaking Medicine News(10 mins):Health News:SRO Surgeon Dr. Nathan Ehmer Backs Up Latest Study That Total Hip Replacement Surgery Patients Are Resuming Normal Activities Sooner 2Health News:SRO Surgeon Dr. Nathan Ehmer Backs Up Latest Study That Total Hip Replacement Surgery Patients Are Resuming Normal Activities Sooner 3Health News:Case Mason Consolidates Operations to Larger Facility for Increased Efficiency, Improved Service 2Health News:Case Mason Consolidates Operations to Larger Facility for Increased Efficiency, Improved Service 3Health News:PeopleKeys to Air “Managing Stress: Train the Trainer” DISC Webinar 2Health News:Addictions Training Institute Announces New Online Certificate Program for Alcohol and Drug Counselors 2
    ... use of oral chemotherapy in US cancer centres need to ... ,Common malignancies can be treated with oral chemotherapy ... and internationally. ,Researchers from Boston set out ... centres for the provision of oral chemotherapy. Forty-two centres took ...
    ... rest on the couch to recover before returning to sports, ... at least not yet. // ,One Ohio State University ... devices for the heart will be put to use temporarily ... Right now, such heart pumps, known commonly as ventricular assist ...
    ... Vanderbilt Kennedy Center for Research on Human Development has ... and behavioral //and neurological problems in the child. ... Gregg Stanwood, Ph.D., and Pat Levitt, Ph.D., have elaborated ... rabbits, which caused a prolonged displacement of dopamine receptors ...
    ... the onset of type 1 diabetes in mice prone ... receptor on the surface of immune T-cells. // This ... journal Diabetes, have significant implications for the prevention of ... Americans have type 1 diabetes, an autoimmune disorder in ...
    ... warns a senior doctor in this week’s BMJ. ... causes of delayed discharge are associated with inadequate care ... medication errors. ,This crisis is the result ... care, and poor leadership, and it is directly harming ...
    ... Canisius College is giving children with Asperger’s Disorder (AD) ... ,Asperger’s Disorder is a high functioning form of ... inability to recognize emotions in others and narrow, often ... Spectrum Disorders Research Consortium, Canisius professors Robert E. Nida, ...
    Cached Medicine News:Health News:Pumps Someday May Allow Patients to Recover Their Own Hearts 2Health News:Pumps Someday May Allow Patients to Recover Their Own Hearts 3Health News:Cocaine During Pregnancy can Cause Behavioral and Neurological Problems in the Child 2Health News:Cocaine During Pregnancy can Cause Behavioral and Neurological Problems in the Child 3Health News:Antibody Therapy Prevents Type 1 Diabetes 2Health News:Connections Program Offers Hope to Children With Asperger's Disorder 2Health News:Connections Program Offers Hope to Children With Asperger's Disorder 3
    ... a vital dye, used in matured cataract ... fibrous tissue enables the surgeon to see ... preparation of trypan blue combined with sodium ... tolerated following intraocular injection into the anterior ...
    Exclusive oxidized regenerated cellulose technology. The only oxidized regenerated cellulose hemostat line, surgicel absorbable hemostat delivers a unique combination of effectiveness, absorbability,...
    Refkeratometer...
    Portable, easy to align, automatic measurement, automatic fogging. Accurate and dependable readings. Infrared printer communication. Rechargeable battery. Integrates with the TRS-2100 and EPIC-2100 r...
    Medicine Products: